Literature DB >> 1130321

Insulin, glucose and triglyceride relationships in obese African subjects.

B I Joffe, R B Goldberg, H C Seftel, L A Distiller.   

Abstract

Aspects of carbohydrate and lipid metabolism were studied in 50 nondiabetic African subjects living in Johannesburg. Twenty-six of them were overweight, invariably associated with a high-carbohydrate intake. In general, the obese group demonstrated significantly raised serum insulin levels, normal glucose tolerance, normal fasting serum triglycerides, and significantly elevated serum cholesterol concentrations. However, the degree of obesity was not significantly correlated with any of these metabolic variables--notably basal or stimulated insulin levels. This suggests that the obese state, per se, was not the major cause of the hyperinsulinemia, and that other factors influenced individual insulin responses or sensitivity. Inconsistently excessive dietary carbohydrate ingestion and an unusual degree of physical activity may have been important. A striking correlation emerged between fasting serum triglycerides and insulin concentrations (both basal and stimulated); the possibility that this reflects acceleration of hepatic triglyceride synthesis by insulin is discussed. The concept of obesity invariably producing insulin resistance and progressive compensatory hyperinsulinism may not apply in all environmental conditions.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1130321     DOI: 10.1093/ajcn/28.6.616

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  2 in total

Review 1.  Coronary heart disease: outlook for Africa.

Authors:  A R Walker; P Sareli
Journal:  J R Soc Med       Date:  1997-01       Impact factor: 5.344

2.  Adipose cell size in obese Africans: evidence against the existence of insulin resistance in some patients.

Authors:  B I Joffe; R B Goldberg; J Feinstein; A Kark; H C Seftel
Journal:  J Clin Pathol       Date:  1979-05       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.